These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13316626)

  • 21. [OBSERVATIONS ON THE PROTECTIVE ACTION OF INTERFERON IN VIVO].
    BOUDREAULT A; PAVILANIS V
    Rev Can Biol; 1964 Sep; 23():277-83. PubMed ID: 14237160
    [No Abstract]   [Full Text] [Related]  

  • 22. The human pathogenicity of the Newcastle disease virus and its relation to the mumps, fowl plague and influenza viruses.
    SINKOVICS J
    Arch Gesamte Virusforsch; 1957; 7(3):242-57. PubMed ID: 13435736
    [No Abstract]   [Full Text] [Related]  

  • 23. Further studies on the adjuvant effect of an interferon inducer (BRL 5907) on Newcastle disease and avian influenza inactivated vaccines.
    Gough RE; Allan WH; Knight DJ; Lieper JW
    Res Vet Sci; 1975 Sep; 19(2):185-8. PubMed ID: 1172622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mucoprotein derived from human urine which reacts with influenza, mumps, and Newcastle disease viruses.
    TAMM I; HORSFALL FL
    J Exp Med; 1952 Jan; 95(1):71-97. PubMed ID: 14907962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The growth of influenza viruses and Newcastle disease virus in mouse brain.
    CAIRNS HJ
    Br J Exp Pathol; 1951 Apr; 32(2):110-7. PubMed ID: 14848425
    [No Abstract]   [Full Text] [Related]  

  • 26. Lack of identity in neutralizing and hemagglutination-inhibiting antibodies against influenza viruses.
    WALKER DL; HORSFALL FL
    J Exp Med; 1950 Jan; 91(1):65-86. PubMed ID: 15395574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The serology of Newcastle virus infection. III. Prevalence of antibody against Newcastle in individuals closely exposed to the virus and in the absence of conjunctivitis.
    BANG FB; FOARD M
    J Immunol; 1956 May; 76(5):352-6. PubMed ID: 13319715
    [No Abstract]   [Full Text] [Related]  

  • 28. Presence of neutralizing antibodies of Newcastle disease virus in human sera.
    HOWITT BF; BISHOP LK; KISSLING RE
    Am J Public Health Nations Health; 1948 Sep; 38(9):1263-72. PubMed ID: 18880227
    [No Abstract]   [Full Text] [Related]  

  • 29. The toxic properties of massive inoculums of Newcastle disease virus and influenza virus (PR8) for cell strains derived from normal and neoplastic tissue.
    MASON EJ; KAUFMAN N
    Am J Pathol; 1960 Aug; 37(2):231-43. PubMed ID: 14422051
    [No Abstract]   [Full Text] [Related]  

  • 30. Haemagglutination by mumps virus; relationship to Newcastle disease and influenza viruses.
    BURNET FM
    Aust J Sci; 1945 Oct 22-Dec 21; 8():81-3. PubMed ID: 21026695
    [No Abstract]   [Full Text] [Related]  

  • 31. The incidence of neutralizing antibodies for type A and type B influenza virus in normal infants and children.
    LAZARUS AS; WESTFALL RE
    J Immunol; 1948 Jun; 59(2):159-64. PubMed ID: 18864090
    [No Abstract]   [Full Text] [Related]  

  • 32. Transplacental transmission of endogenous interferon in pregnant mice inoculated with influenza or Newcastle disease viruses.
    Korsantiya BM; Smorodintsev AA
    Nature; 1971 Aug; 232(5312):560-1. PubMed ID: 4937499
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of neutralizing (SN) and hemagglutination inhibiting (HI) antibodies on the course of Newcastle disease infection in chickens].
    Borzemska WB
    Pol Arch Weter; 1972; 15(3):495-512. PubMed ID: 4662589
    [No Abstract]   [Full Text] [Related]  

  • 34. Serosurvey for Newcastle disease and avian influenza A virus antibodies in great cormorants from France.
    Artois M; Manvell R; Fromont E; Schweyer JB
    J Wildl Dis; 2002 Jan; 38(1):169-71. PubMed ID: 11838209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative determination of residual virus on red cells by direct infectivity titrations.
    EVANS AS
    J Immunol; 1956 Feb; 76(2):161-8. PubMed ID: 13295604
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential action of Aspergillus glycosidases on the hemagglutinating and neuraminidase activities of influenza and Newcastle disease viruses.
    Bikel I; Knight CA
    Virology; 1972 Jul; 49(1):326-32. PubMed ID: 5064657
    [No Abstract]   [Full Text] [Related]  

  • 37. A case of erythema multiforme with presence of neutralizing antibodies of Newcastle disease virus in serum.
    BABALIAN L
    J Maine Med Assoc; 1956 Aug; 47(8):254-6; passim. PubMed ID: 13357887
    [No Abstract]   [Full Text] [Related]  

  • 38. Resistance of chickens to Newcastle disease virus after inoculation with the B1 and Mukteswar strains and prior to production of neutralizing antibody.
    Watanabe M; Furutani T; Nishimura Y
    Natl Inst Anim Health Q (Tokyo); 1968; 8(2):112-3. PubMed ID: 5712542
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimental production of combination forms of virus. IV. Mixed influenza A-Newcastle disease virus infections.
    GRANOFF A; HIRST GK
    Proc Soc Exp Biol Med; 1954 May; 86(1):84-8. PubMed ID: 13177596
    [No Abstract]   [Full Text] [Related]  

  • 40. [Research on the presence of antibodies inhibiting the hemagglution of avian pseudo-plague virus in bovine, equine, ovine and swine sera].
    Biondi E
    Acta Med Vet (Napoli); 1966; 12(6):567-73. PubMed ID: 6012004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.